Healthcare >> CEO Interviews >> December 14, 1998

Mark L. Levin – Millennium Pharmaceuticals (mlnm)

MARK L. LEVIN has served as Chairman of the Board of Directors of Millennium Pharmaceuticals, Inc. since March 1996, Chief Executive Officer of the Company since November 1994 and as a director of the Company since inception. From 1987 to 1994, Mr. Levin was a partner at Mayfield Fund, a venture capital firm, and co-director of its Life Science Group. While employed with Mayfield, Mr. Levin was the founding Chief Executive Officer of several biotechnology and biomedical companies, including Cell Genesys Inc., CytoTherapeutics Inc., Tularik Inc and Focal, Inc. Mr. Levin holds an M.S. in Chemical and Biomedical Engineering from Washington University. Mr. Levin also serves on the Board of Directors of CytoTherapeutics, Tularik and Focal. Profile
TWST: Could you give us a quick overview and a little bit of the history

of the company just to kind of set the stage for our readers?

Mr. Levin: We started working on the development of